The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

There is no “the” vaccine. There are at least two mRNA vaccines (Moderna and Pfizer) and a number of different non-mRNA ...

Novavax Inc. closed 71.00% below its 52-week high of $23.86, which the company reached on June 6th.

In a move that caught much of the medical world off guard, the CDC has stepped back from recommending Covid-19 vaccinations for healthy children and pregnant women. Health and Human […] The post CDC ...

“We are evolving our organization’s capabilities and different roles across the company, including those on our leadership ...

Just a week after the FDA updated its stance on new COVID-19 | The CDC's recommended immunization schedule no longer includes ...

The move underscores the profound impact HHS Secretary Robert F. Kennedy is exerting on immunizations in the U.S.

The Centers for Disease Control and Prevention will no longer recommend routine Covid shots for healthy children and pregnant ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

Robert F. Kennedy Jr. said the vaccine had been removed from the CDC's immunization schedule, a guideline used by health providers to determine which vaccines children should receive and when ...